Craig Thompson

Biography

Craig joins Anthera with over 20 years of experience in the pharmaceutical and healthcare industries. He has a proven track record in product development, global brand management, product positioning, access and reimbursement, including the strategic marketing of a number of industry-leading drugs. Prior to Anthera, Craig was the Chief Operating Officer for Tetraphase Pharmaceuticals where he oversaw the development and implementation of the marketing, access & reimbursement and sales strategy as well as the business development and the commercial manufacturing for the company. Prior to Tetraphase, he served as Chief Commercial Officer for Trius Therapeutics through the acquisition of Trius by Cubist Pharmaceuticals, Inc. in September 2013. Craig led the planning of the commercial strategy, was actively involved in negotiating a regional partnership with Bayer as well as the actively involved in the acquisition of the company by Cubist. During his tenure he participated in three company financing raising $115 MM. Prior to Trius, Mr. Thompson served in various global and U.S. commercial roles at Pfizer Inc. from 2003 to December 2010 ultimately serving as Vice President of Marketing for Pfizer’s Specialty Care Business Unit, where he was directly responsible for the U.S. commercial strategy for a portfolio of products with more than $1.5 billion in annual U.S. sales. From 1992 to 2003, Mr. Thompson served in positions of increasing responsibility at Merck & Co., Inc., where he most notably worked on commercial planning and marketing activities for the company’s major cardiovascular brands. Mr. Thompson holds a Bachelor’s degree in Commerce from McMaster University and an M.B.A. from the University of Notre Dame.

Research Interest

Implementation of the marketing, access & reimbursement and sales strategy as well as the business development and the commercial manufacturing.